HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John D Hazle Selected Research
John D Hazle Research Topics
Disease
20
Neoplasms (Cancer)
03/2022 - 02/2002
4
Prostatic Neoplasms (Prostate Cancer)
08/2011 - 07/2006
3
Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2018
3
Necrosis
12/2010 - 04/2002
2
Neoplasm Metastasis (Metastasis)
11/2021 - 05/2010
2
Head and Neck Neoplasms (Head and Neck Cancer)
07/2015 - 10/2011
2
Carcinogenesis
11/2012 - 05/2012
2
Hyperthermia
05/2008 - 07/2006
2
Veterinary Venereal Tumors (Transmissible Venereal Tumor)
08/2005 - 02/2003
1
Triple Negative Breast Neoplasms
04/2022
1
Pathologic Complete Response
04/2022
1
Lymphoma (Lymphomas)
03/2022
1
Liver Neoplasms (Liver Cancer)
11/2021
1
Cholangiocarcinoma
11/2021
1
Rectal Neoplasms (Rectal Cancer)
07/2018
1
Hepatitis
01/2018
1
Brain Neoplasms (Brain Tumor)
01/2018
1
Inflammation (Inflammations)
01/2018
1
Liver Diseases (Liver Disease)
01/2018
1
Liver Cell Adenoma (Hepatocellular Adenoma)
01/2018
1
Deglutition Disorders (Dysphagia)
02/2016
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
02/2016
1
Squamous Cell Carcinoma of Head and Neck
12/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2015
1
Tics (Tic)
07/2015
1
Glioblastoma (Glioblastoma Multiforme)
11/2014
1
Breast Neoplasms (Breast Cancer)
05/2012
1
Mouth Neoplasms (Oral Cancer)
10/2011
1
Hypoxia (Hypoxemia)
12/2010
1
Sarcoma (Soft Tissue Sarcoma)
05/2010
1
Leiomyosarcoma
05/2010
1
Fibrosarcoma
05/2010
1
Adenocarcinoma
08/2003
1
Residual Neoplasm
02/2003
Drug/Important Bio-Agent (IBA)
4
Gold
IBA
10/2011 - 05/2008
3
Gadolinium
IBA
01/2006 - 04/2002
2
Contrast Media
IBA
07/2015 - 01/2006
2
Trastuzumab (Herceptin)
FDA Link
11/2012 - 05/2012
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
11/2012 - 05/2012
2
Protons (Proton)
IBA
01/2011 - 08/2003
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
03/2022
1
ibrutinib
IBA
03/2022
1
thiamine triphosphorate (TTP)
IBA
09/2019
1
Sorafenib (BAY 43-9006)
FDA Link
05/2019
1
Biomarkers (Surrogate Marker)
IBA
05/2019
1
Solutions
IBA
01/2019
1
Catenins
IBA
01/2018
1
Pyruvic Acid (Pyruvate)
IBA
11/2015
1
amino-propyl-triethoxysilane
IBA
11/2014
1
Integrins
IBA
11/2014
1
Ligases (Synthetase)
IBA
05/2012
1
Glucose (Dextrose)
FDA Link
Generic
05/2012
1
Phosphotransferases (Kinase)
IBA
05/2012
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
05/2012
1
ferric oxide (iron oxide)
IBA
10/2011
1
Cetuximab (Erbitux)
FDA Link
10/2011
1
Eosine Yellowish-(YS) (Eosin)
IBA
12/2010
1
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2010
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
05/2010
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
05/2010
1
Silicon Dioxide (Silica)
FDA Link
Generic
04/2009
1
Pharmaceutical Preparations
IBA
10/2007
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
07/2006
1
Proteins (Proteins, Gene)
FDA Link
07/2006
1
Explosive Agents (Explosives)
IBA
01/2004
1
Gadolinium DTPA (Magnevist)
FDA Link
02/2003
Therapy/Procedure
13
Therapeutics
01/2018 - 02/2002
8
Lasers (Laser)
01/2018 - 02/2003
3
Radiotherapy
02/2016 - 07/2006
3
Laser Therapy (Surgery, Laser)
10/2011 - 07/2006
2
Neoadjuvant Therapy
04/2022 - 07/2018
1
Microspheres (Microsphere)
11/2021
1
Chemoradiotherapy
12/2015
1
Brachytherapy
08/2011
1
Drug Therapy (Chemotherapy)
07/2006
1
Intravenous Administration
01/2006
1
Transplantation
08/2005
1
Transjugular Intrahepatic Portasystemic Shunt
01/2004
1
Solid-State Lasers
01/2004
1
Semiconductor Lasers
01/2004
1
Aftercare (After-Treatment)
04/2002
1
Ultrasonic Therapy
02/2002